Evaluation of oocyte maturity in patients undergoing ICSI and R-FSH treatment;La valutazione della maturazione ovocitaria in pazienti sottoposte ad ICSI e trattate con R-FSH

Minerva Ginecologica

Volumn 53, Issue 3, 2001, Pages 157-163

  Fasolino, A ^a,b,c,d   Longo, V ^b,c   Capece, G ^b,c   Trotta, R ^b,c   Franco, F ^b,c   Fasolino, M C ^b,c  

^a Div di Ostetricia e Ginecologia   (Italy)

^b Ctro Med della Riproduzione (CMR)   (Italy)

^c Azienda Ospedaliera OORR   (Italy)

^d Div di Ostetricia e Ginecologia   (Italy)

Author keywords

Embryo physiology; Fertilisation in vitro; Fertilization; Oocytes cythology; Sperm injections, intracytoplasmatic

Indexed keywords

RECOMBINANT FOLLITROPIN; UROFOLLITROPIN; FOLLITROPIN;

ARTICLE; BLASTOMERE; CELL STRUCTURE; EMBRYO; FERTILIZATION; HORMONAL THERAPY; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE CLEAVAGE; OOCYTE MATURATION; PREGNANCY RATE; ZONA PELLUCIDA; ADULT; COMPARATIVE STUDY; CYTOLOGY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; OOCYTE; PHYSIOLOGY; PREGNANCY; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

ADULT; EMBRYO; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; OOCYTES; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS;

EID: 0034743202     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Hughes EG, Sagle HA, Fedorkow DM, Koppler P Van der, Daya S, Collins JA. The routine use of gonadotropin releasing hormone agonist prior to in vitro fertilization and gamete intrafallopian transfer: a metarralysis of randomized controlled trials. Fertil Steril 1992;58:888-96.
2. Daya S, Gumby J, Hughes EG, Collins JA, Sagle HA. Follicle stimulating hormone versus Human menopausal gonadotropin for in vitro fertilization cycles: a metanalysis. Fertil Steril 1995;64:347-54.
3. Van Steirteghern AC, Nogy Z, Joris H, Liu J, Staessen C, Smitz J et al. High fertilization and implantation rate after ICSI. Hum Reprod 1993;8:1061-66.
4. Staessen C, Camus M, Bollen N, Devroey P, Van Steirteghern A. The relationship between embryo quality and the occurrence of multiple pregnancies. Fertil Steril 1992;3:626-30.
5. Hedon B, Out HJ, Hugnes JN, Carnier B, Cohen J, Lopes P et al. Efficacy and safety of recombinant follicle stimulating hormone in infertil women pituitary suppressed with Triptorelin under going in vitro, fertilization: prospective, randomized, assessorblind, multicentre trial. Hum Reprod 1995;10:3102-6.
6. Out HJ, Mennaerts BHJL, Driessen SGAJ, Coelingh Bennink HJT. A prospective, randomized, assessorblind, multicentre study comparing recombinant and urinary follicle stimulating hormone in in vitro fertilization. Hum Reprod 1995;10:2534-40.
7. Out HJ, Mannaerts BMJL, Driessen SGM. Recombinant follicle stimulating hormone (rhFSH) in assisted reproduction: more oocytes, more pregnancy. Results from five comperative studies. Hum Reprod Update 1996;2:162-71.
8. Balaben B, Urman B, Sertac A, Alatas C, Aksoy S, Mercan R. Ooeyte morphology does not affect fertilization rate, embryo quality and implantation rate after intracytoplasmatic sperm injection. Hum Reprod 1998;13:3431-3